Switch theme
Sign up to access all valuation multiples
Cessatech AS is a pharmaceutical company committed to developing and commercializing evidence-based medicines for children for the treatment of paediatric acute pain. Its product (CT001) is an analgesic nasal spray for the treatment of acute and planned painful procedures in children. Its other products CT002 which is a Non-invasive nasal spray and CT003 which is a local anaesthetic gel are in different stages development.
2020
4
Last FY Revenue $0.4M
Last FY EBITDA -$2.9M
$34.3M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Cessatech achieved revenue of $0.4M and an EBITDA of -$2.9M.
Cessatech expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Cessatech valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $0.4M | XXX | XXX | XXX |
| Gross Profit | XXX | n/a | XXX | XXX | XXX |
| Gross Margin | XXX | n/a | XXX | XXX | XXX |
| EBITDA | XXX | -$2.9M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -766% | XXX | XXX | XXX |
| EBIT | XXX | -$2.9M | XXX | XXX | XXX |
| EBIT Margin | XXX | -766% | XXX | XXX | XXX |
| Net Profit | XXX | -$2.2M | XXX | XXX | XXX |
| Net Margin | XXX | -590% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Cessatech's stock price is DKK 13 (or $2).
Cessatech has current market cap of DKK 235M (or $35.3M), and EV of DKK 228M (or $34.3M).
See Cessatech trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $34.3M | $35.3M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Cessatech has market cap of $35.3M and EV of $34.3M.
Cessatech's trades at 91.7x EV/Revenue multiple, and -12.0x EV/EBITDA.
Equity research analysts estimate Cessatech's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cessatech's P/E ratio is not available.
See valuation multiples for Cessatech and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $35.3M | XXX | $35.3M | XXX | XXX | XXX |
| EV (current) | $34.3M | XXX | $34.3M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 91.7x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -12.0x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -12.0x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -16.0x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -31.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCessatech's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.8M for the same period.
Cessatech's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Cessatech's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Cessatech and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -766% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.8M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 866% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cessatech acquired XXX companies to date.
Last acquisition by Cessatech was XXXXXXXX, XXXXX XXXXX XXXXXX . Cessatech acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Cessatech founded? | Cessatech was founded in 2020. |
| Where is Cessatech headquartered? | Cessatech is headquartered in Sweden. |
| How many employees does Cessatech have? | As of today, Cessatech has 4 employees. |
| Is Cessatech publicy listed? | Yes, Cessatech is a public company listed on SAT. |
| What is the stock symbol of Cessatech? | Cessatech trades under CESSA ticker. |
| When did Cessatech go public? | Cessatech went public in 2020. |
| Who are competitors of Cessatech? | Similar companies to Cessatech include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Cessatech? | Cessatech's current market cap is $35.3M |
| Is Cessatech profitable? | Yes, Cessatech is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
